To the Editor Kitz et al1 evaluated the prognostic value of total mesorectal excision (TME) plane in patients with rectal cancer. Total mesorectal excision plane quality was grouped into 3 categories: mesorectal, intramesorectal, and muscularis propria. One end point was disease-free survival (DFS). The authors quantified the between-group differences using 3-year event-free rates and hazard ratios (HRs). Three-year DFS rate estimates for mesorectal, intramesorectal, and muscularis propria TME were 75.9% (95% CI, 73.1-78.8), 68.4% (95% CI, 61.6-76.0), and 67.2% (95% CI, 55.6-81.3), respectively. Because these confidence intervals overlap, it is unclear whether there is a true difference between certain pairs, eg, between intramesorectal and muscularis propria TME. Moreover, in Figure 2A,1 the DFS curves extend up to 60 months. Thus, the 3-year event rate provides a local profile of DFS only. To use data after 3 years, the authors reported HRs for DFS (intramesorectal vs mesorectal TME: HR, 1.35; 95% CI, 1.01-1.80; muscularis propria vs mesorectal TME: HR, 1.73; 95% CI, 1.13-2.66). However, it is difficult to interpret HRs in the clinical context. The hazard is not a chance or probability measure and therefore is not equivalent to risk. Thus, an HR of 1.35 cannot be translated into a 35% risk increase. Also, no reference hazard value from mesorectal TME was provided. If mesorectal TME hazard is low, a 35% increase in hazard may not be clinically significant. Other issues and concerns in using HRs to quantify between-group differences have been discussed extensively.2-4
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Sun R, Lee H, Wei L. Interpreting the Long-term Prognostic Value of Total Mesorectal Excision Plane Quality in Rectal Adenocarcinoma. JAMA Surg. 2019;154(1):96. doi:10.1001/jamasurg.2018.3540
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: